IgM

Immunoglobulin M

Immune & Inflammation

What is Immunoglobulin M?

Immunoglobulin M (IgM) is the largest antibody molecule and the first immunoglobulin produced by the body in response to a new infection or antigen exposure. IgM exists primarily as a pentamer—five antibody units joined together—giving it ten antigen-binding sites and making it extremely efficient at agglutinating (clumping) pathogens and activating the complement system. IgM accounts for approximately 5–10% of total serum immunoglobulins.

IgM is produced by B lymphocytes as the initial immune response, typically appearing within days of antigen exposure and declining as the more targeted IgG response matures over weeks. Because of this timing, the presence of IgM antibodies specific to a pathogen indicates acute or recent infection, while IgG indicates past infection or immunization. IgM is largely confined to the intravascular space due to its large pentameric size (molecular weight ~900 kDa), making it particularly effective at clearing bloodstream pathogens. Quantitative IgM measurement is used to evaluate immune deficiency, diagnose Waldenström macroglobulinemia, and assess the humoral immune response.

Why It Matters

IgM is the immune system's first responder. Elevated IgM specific to a pathogen signals acute infection, which is critical for timely diagnosis of conditions like hepatitis A, Epstein-Barr virus, and congenital TORCH infections. Isolated IgM deficiency increases susceptibility to recurrent infections, particularly with encapsulated bacteria. Markedly elevated monoclonal IgM (IgM paraprotein) is the hallmark of Waldenström macroglobulinemia, a B-cell lymphoma that can cause hyperviscosity syndrome—a medical emergency. Monitoring IgM helps guide treatment in immunodeficiency and lymphoproliferative disorders.

Normal Reference Ranges

GroupRangeUnit
Adult Men46–304mg/dL
Adult Women37–286mg/dL
Children (1–5 years)43–207mg/dL
Neonates5–30mg/dL

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High IgM Levels Mean

Common Causes

  • Acute infection (viral, bacterial, parasitic)
  • Waldenström macroglobulinemia (lymphoplasmacytic lymphoma)
  • Primary biliary cholangitis (characteristically elevated IgM)
  • Hyper-IgM syndrome
  • Autoimmune diseases (rheumatoid arthritis, SLE)
  • Chronic hepatitis
  • Congenital infections (elevated IgM in neonate indicates in-utero infection)

Possible Symptoms

  • Symptoms of acute infection (fever, malaise, lymphadenopathy)
  • Hyperviscosity syndrome (blurred vision, headache, mucosal bleeding)
  • Peripheral neuropathy
  • Hepatosplenomegaly
  • Fatigue and weight loss (in malignancy)
  • Raynaud phenomenon (cold agglutinin disease)

What to do: Context determines management. If IgM elevation accompanies acute infection, treat the infection. If IgM is markedly elevated (>1,000 mg/dL), check for monoclonal IgM by serum protein electrophoresis (SPEP) and immunofixation to evaluate for Waldenström macroglobulinemia. Hyperviscosity syndrome (IgM typically >4,000 mg/dL) requires emergent plasmapheresis. Elevated IgM with cholestatic liver enzymes should prompt evaluation for primary biliary cholangitis (anti-mitochondrial antibodies). In neonates, elevated IgM (>20 mg/dL) at birth suggests congenital infection and warrants TORCH workup.

What Low IgM Levels Mean

Common Causes

  • Selective IgM deficiency (primary immunodeficiency)
  • Common variable immunodeficiency (CVID)
  • X-linked agammaglobulinemia (Bruton disease)
  • Multiple myeloma (non-IgM type, with immune paresis)
  • Chronic lymphocytic leukemia
  • Immunosuppressive therapy
  • Protein-losing enteropathy or nephrotic syndrome

Possible Symptoms

  • Recurrent sinopulmonary infections
  • Recurrent otitis media (especially in children)
  • Invasive infections with encapsulated bacteria (pneumococcus, meningococcus)
  • Recurrent sepsis
  • Chronic diarrhea (in some immunodeficiency syndromes)

What to do: Low IgM should be evaluated in the context of total immunoglobulin levels (IgG, IgA). If all are low, evaluate for CVID, X-linked agammaglobulinemia, or secondary causes (medications, protein loss). Isolated IgM deficiency is relatively uncommon but associated with increased infection risk. Patients with symptomatic immunodeficiency may benefit from prophylactic antibiotics or immunoglobulin replacement therapy (though IgM is not well-replaced by standard IVIG, which is predominantly IgG). Vaccination responses should be assessed to determine functional antibody production.

When Is IgM Testing Recommended?

  • When evaluating recurrent or unusual infections suggesting immunodeficiency
  • When acute infection needs to be distinguished from past infection
  • When Waldenström macroglobulinemia is suspected
  • When evaluating neonatal congenital infection (TORCH screen)
  • When primary biliary cholangitis is being investigated
  • As part of an immunoglobulin panel in immune workup

Frequently Asked Questions

IgM is the first antibody produced when the immune system encounters a new pathogen. During a primary immune response, B cells initially produce IgM before undergoing class switching to produce IgG, IgA, or IgE. This means IgM-specific antibodies to a pathogen appear within days of exposure and peak at 1–2 weeks, while IgG antibodies appear later (after 1–3 weeks) and persist long-term. Detecting pathogen-specific IgM therefore indicates acute or very recent infection. After the infection resolves, IgM levels decline over weeks to months while IgG persists, providing long-term immunity. This IgM-to-IgG transition is the basis for distinguishing acute from past infections in many serologic tests.
Waldenström macroglobulinemia (WM) is a rare B-cell lymphoproliferative disorder characterized by bone marrow infiltration with lymphoplasmacytic cells that produce a monoclonal IgM protein. It accounts for about 1–2% of hematologic malignancies and typically affects older adults (median age 65). The monoclonal IgM can cause hyperviscosity syndrome (when IgM levels exceed ~4,000 mg/dL), characterized by blurred vision, headache, mucosal bleeding, and neurologic symptoms. IgM can also act as a cryoglobulin (precipitating in cold temperatures) or cold agglutinin (causing autoimmune hemolytic anemia in cold conditions). Over 90% of WM patients carry the MYD88 L265P mutation. Treatment includes rituximab-based regimens, BTK inhibitors (ibrutinib, zanubrutinib), and plasmapheresis for hyperviscosity.
Hyper-IgM syndrome is a group of rare primary immunodeficiencies characterized by normal or elevated IgM with markedly low IgG and IgA. The most common form is X-linked hyper-IgM syndrome (XHIM), caused by mutations in the CD40 ligand gene (CD40L/CD154) on T helper cells. CD40L is required for B cells to undergo class-switch recombination (the process of switching from IgM production to IgG, IgA, or IgE). Without this signal, B cells are stuck producing IgM. Patients present in early childhood with recurrent sinopulmonary infections, Pneumocystis jirovecii pneumonia, chronic diarrhea from Cryptosporidium, and are at increased risk of liver disease and lymphoma. Treatment involves immunoglobulin replacement therapy, prophylactic antibiotics, and in some cases hematopoietic stem cell transplantation.

Related Biomarkers

WBCWhite Blood CellsCRPC-Reactive ProteinESRErythrocyte Sedimentation RateALBAlbumin

Want your IgM levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.